HAYWARD, Calif., Feb. 15, 2011 /PRNewswire/ -- Solta Medical, Inc.
(Nasdaq: SLTM), the pioneer in fractional resurfacing and
non-invasive skin tightening and a global market leader in
aesthetic skin treatments, today announced that it has named
Linda Graebner to its Board of
Directors, effective immediately. Ms. Graebner is the founder
and managing partner of LG Associates, a consulting firm which
specializes in creating and implementing business growth plans for
consumer, manufacturing and retail businesses. Her
appointment brings the total number of directors on the Solta board
to seven.
"Linda's focus throughout her career has been in the consumer
products industry, an emerging market for Solta," said Stephen J. Fanning, Chairman of the Board,
President and CEO of Solta Medical, Inc. "She has extensive
executive experience in driving the growth and development of
leading consumer brands and companies. Her expertise ranges
from strategic development and capital formation to manufacturing
and product innovation. She is well-versed in the execution
of targeted e-commerce initiatives and retail distribution to drive
awareness and sales of consumer products. We believe Linda
will add valuable insight as we expand into the high-end personal
care market, and we look forward to her contributions."
Prior to founding LG Associates, Ms Graebner was the President
and CEO of Tilia Inc., a leading marketer and manufacturer of
specialty kitchen products. During her 12 year tenure at
Tilia, she created and executed the strategic plan for the company
that resulted in a new category in the housewares industry and a
financial turnaround. Under her leadership, Tilia expanded
its product line, drove significant cost savings by shifting
product sourcing from Europe to
the Far East, and strengthened its financial structure. The
company grew from $9 million in
revenue with significant losses when Ms. Graebner joined Tilia to
over $200 million in revenue with
strong EBITDA and cash flow prior to its sale to Jarden Corporation
in 2002.
Ms. Graebner's experience also includes various executive level
positions in sales and marketing, new business development and
R&D at Dole Food Company, a $3
billion food producer. Prior to Dole, Ms. Graebner
held senior marketing, business development and strategic planning
positions at James River Corporation, as well as Crown Zellerbach,
prior to its acquisition by James
River. She began her career with Booz, Allen &
Hamilton.
"I am excited to join the Solta Medical Board as the Company
begins to expand its innovative aesthetic solutions into the
high-end personal care market," commented Ms. Graebner.
"Solta Medical has built a strong foundation and reputation
with its core physician customer base. It has successfully
begun initial product innovations and marketing efforts to bring
awareness of its unique, safe and effective treatments for a
variety of skin conditions directly to consumers, and I look
forward to helping the Company continue its momentum as a member of
the Board."
In addition to Solta Medical, Ms. Graebner is currently serving
on several Boards: Distant Lands Coffee and Evriholder Products LLP
(kitchen, cleaning and personal care). She has served as the
Chairman of the Board of the International Housewares Association
(IHA) and currently leads a Bay Area CEO Group sponsored by IHA.
She also serves as Group Chair of the Silicon Valley Chapter
of the Women Presidents' Organization and as a Chair of the Chief
Executive Council in San
Francisco. Ms. Graebner has a B.S. degree in
mathematics from Purdue University and
an M.B.A. from Stanford University.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's four premier brands: Thermage®,
Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative,
non-invasive radiofrequency procedure for tightening and contouring
skin. As the leader in fractional laser technology, Fraxel delivers
minimally invasive clinical solutions to resurface aging and sun
damaged skin. Isolaz is the only laser or light based system
indicated for the treatment of inflammatory acne, comedonal acne,
pustular acne, and mild-to-moderate inflammatory acne. CLARO is a
personal care acne system that is the only FDA cleared
over-the-counter IPL device that uses a powerful combination of
both heat and light to clear skin quickly and naturally. Since
2002, approximately one million Thermage, Fraxel and Isolaz
procedures have been performed in over 100 countries. For more
information about Solta Medical, call 1-877-782-2286 or log on to
www.Solta.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995, including statements regarding the anticipated shipment dates
of the newly announced products and contributions of the new
products to future growth. Forward-looking statements are based on
management's current expectations and are subject to risks and
uncertainties, which may cause actual results to differ materially
from the forward looking statements contained herein. Factors that
might cause such a difference include the possibility that the
market for the sale of these products and initiatives does not
develop as expected or that difficulties arise in the production
and shipment of these products arise. Further information on
potential risk factors that could affect Solta Medical's business
are detailed in its Form 10-Q for the quarter ended September 30, 2010. Solta Medical undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
they were made, or to reflect the occurrence of unanticipated
events.
© 2010 Solta Medical, Inc. All rights
reserved. Thermage, Fraxel, Fraxel re:store, Isolaz,
Clear+Brilliant, and Solta Medical are trademarks or registered
trademarks of Solta Medical, Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.